Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

VGHCX vs IXJ overlap: 55% of top holdings shared

Bottom line

How much do VGHCX and IXJ overlap?

55% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 45.4% of VGHCX's assets and 48.3% of IXJ's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

VGHCXIXJ
Weight overlap (top 25)55%
Shared holdings13
Weight in shared holdings45.4%48.3%
Total positions97124
Expense ratio0.33%0.38%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings VGHCX and IXJ have in common

Holding% of VGHCX% of IXJOverlap
Eli Lilly & Co8.61%10.93%8.61%
Merck & Co Inc5.44%4.12%4.12%
Johnson & Johnson4.83%7.04%4.83%
AstraZeneca PLC4.59%3.76%3.76%
UnitedHealth Group Inc4.05%4.40%4.05%
Gsk Plc3.00%1.38%1.38%
Intuitive Surgical Inc2.52%1.83%1.83%
CVS Health Corp2.52%1.71%1.71%
Vertex Pharmaceuticals Inc2.36%1.64%1.64%
AbbVie Inc2.30%5.12%2.30%
Danaher Corp2.18%1.56%1.56%
Elevance Health Inc1.83%1.09%1.09%
Roche Holding AG1.18%3.75%1.18%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in VGHCX

  1. Edwards Lifesciences Corp — 2.56%
  2. Cencora Inc — 2.47%
  3. Regeneron Pharmaceuticals Inc — 2.14%
  4. Novartis AG — 1.91%
  5. Argenx SE — 1.68%
  6. HCA Healthcare Inc — 1.68%
  7. Ucb Sa — 1.67%
  8. Boston Scientific Corp — 1.53%
  9. Agilent Technologies Inc — 1.49%
  10. Biogen Inc — 1.46%
  11. Galderma Group AG — 1.37%
  12. Dexcom Inc — 1.18%

Only in IXJ

  1. Novartis AG — 3.71%
  2. Amgen Inc. — 2.54%
  3. Thermo Fisher Scientific Incorporated — 2.42%
  4. Abbott Laboratories — 2.05%
  5. Gilead Sciences, Inc. — 2.04%
  6. Novo Nordisk A/s — 1.99%
  7. Pfizer Inc. — 1.78%
  8. Bristol-myers Squibb Company — 1.53%
  9. Stryker Corporation — 1.41%
  10. Medtronic Public Limited Company — 1.30%
  11. Sanofi Sa — 1.18%
  12. Mckesson Corporation — 1.18%

Asset mix

Asset typeVGHCXIXJ
Stocks97.6%99.6%
Repurchase agreements2.2%—
Cash & short-term funds0.1%1.3%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryVGHCXIXJ
US77.6%70.6%
CH4.5%10.4%
GB7.6%5.8%
JP4.8%3.7%
BE3.4%0.5%
DK1.4%2.3%
FR—2.0%
DE—1.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do VGHCX and IXJ overlap?
About 55% by weight. 13 securities appear in both funds' top 25 holdings; they make up 45.4% of VGHCX's assets and 48.3% of IXJ's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do VGHCX and IXJ have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, Merck & Co Inc, UnitedHealth Group Inc, AstraZeneca PLC.
Should I own both VGHCX and IXJ?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, VGHCX or IXJ?
IXJ is broader, with 124 positions versus 97 for VGHCX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.